On November 2, 2017 IntelGenx Technologies Corp., (TSX VENTURE:IGX)(OTCQX:IGXT), reported that it will release its third quarter 2017 financial results after market close on November 9, 2017 (Press release, IntelGenx, NOV 2, 2017, View Source;Conference-Call-to-Follow/default.aspx [SID1234521515]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

An accompanying conference call will be hosted by Dr. Horst G. Zerbe, President and Chief Executive Officer, and Mr. Andre Godin, Executive Vice-President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:

Date: Thursday, November 9, 2017
Time: 4:30 p.m. ET
Conference dial-in: (833) 231-8269
International dial-in: (647) 689-4114
Conference ID: 4994849
Webcast Registration: Click here

Following the live call, a replay will be available on the Company’s website, www.intelgenx.com, under “Investor Relations”.